Research

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care

Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama and Jon D Emery
British Journal of General Practice 2019; 69 (689): e836-e842. DOI: https://doi.org/10.3399/bjgp19X706841

Article Information

vol. 69 no. 689 e836-e842
DOI 
https://doi.org/10.3399/bjgp19X706841
PubMed 
31636127
Published By 
Royal College of General Practitioners
Print ISSN 
0960-1643
Online ISSN 
1478-5242
History 
  • Received July 7, 2019
  • Revision requested July 18, 2019
  • Accepted August 19, 2019
  • Published online November 28, 2019.

Article Versions

Copyright & Usage 
© British Journal of General Practice 2019

Author Information

  1. Jennifer G McIntosh, BAppSci, MPH, PhD, Senior research fellow
  1. Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.
  1. Jesse Minshall, BSc, MD, Medical resident
  1. Western Health, Melbourne, Australia.
  1. Sibel Saya, BSc, MGC, PhD candidate
  1. Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia.
  1. Adrian Bickerstaffe, BCompSci(Hons), PhD, Head of research computing
  1. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Australia.
  1. Nadira Hewabandu, BSc(Hons), Senior informatics officer
  1. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Australia.
  1. Ashleigh Qama, BSc(Hons), Epidemiologist
  1. WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Melbourne, Australia.
  1. Jon D Emery, MA, MRCGP, FRACGP, DPhil, Herman professor of primary care cancer research
  1. Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia; Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, UK.
  1. Address for correspondence
    Jennifer McIntosh, Centre for Cancer Research and Department of General Practice, Level 10, 305 Grattan Street, Carlton, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia. Email: jennifer.mcintosh{at}unimelb.edu.au
View Full Text

Article usage

Article usage: October 2019 to June 2020

AbstractFullPdf
Oct 201930498
Nov 2019541279
Dec 20195592819
Jan 202020068
Feb 202011532
Mar 202010776
Apr 20208621
May 20204862
Jun 20206211

Statistics from Altmetric.com

Back to top

In this issue

British Journal of General Practice: 69 (689)
British Journal of General Practice
Vol. 69, Issue 689
December 2019
Download PDF
Download PowerPoint
Article Alerts
Email Article
Citation Tools

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care
Jennifer G McIntosh, Jesse Minshall, Sibel Saya, Adrian Bickerstaffe, Nadira Hewabandu, Ashleigh Qama, Jon D Emery
British Journal of General Practice 2019; 69 (689): e836-e842. DOI: 10.3399/bjgp19X706841
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Keywords

Advertisement

 
 

British Journal of General Practice